Latest news with #CTILogistics
Yahoo
02-06-2025
- Business
- Yahoo
ASX Penny Stocks To Watch In June 2025
The ASX200 is set to open slightly lower today, influenced by mixed performances in the US markets and ongoing global trade tensions. Despite these broader market challenges, penny stocks—often representing smaller or newer companies—continue to offer intriguing opportunities for growth. While the term 'penny stock' may seem outdated, these investments can still reveal hidden value when backed by strong financial health and solid fundamentals. Name Share Price Market Cap Financial Health Rating Lindsay Australia (ASX:LAU) A$0.71 A$225.19M ★★★★☆☆ CTI Logistics (ASX:CLX) A$1.85 A$149.01M ★★★★☆☆ Accent Group (ASX:AX1) A$1.90 A$1.14B ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$1.565 A$73.83M ★★★★★★ IVE Group (ASX:IGL) A$2.55 A$393.16M ★★★★★☆ GTN (ASX:GTN) A$0.61 A$116.42M ★★★★★★ Bisalloy Steel Group (ASX:BIS) A$3.50 A$166.08M ★★★★★★ Regal Partners (ASX:RPL) A$2.33 A$783.26M ★★★★★★ Tasmea (ASX:TEA) A$2.99 A$699.78M ★★★★★☆ SHAPE Australia (ASX:SHA) A$3.29 A$272.21M ★★★★★★ Click here to see the full list of 1,000 stocks from our ASX Penny Stocks screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Emerald Resources NL is involved in the exploration and development of mineral reserves in Cambodia and Australia, with a market cap of A$3.12 billion. Operations: The company generates revenue primarily from its mine operations, amounting to A$427.32 million. Market Cap: A$3.12B Emerald Resources demonstrates strong financial health with its interest payments well covered by EBIT and operating cash flow covering debt over tenfold. Its net profit margin has improved, reflecting a stable growth trajectory, while earnings have consistently outpaced the industry average. The company trades significantly below estimated fair value and has not diluted shareholders recently. Despite a low return on equity, Emerald's cash reserves exceed total debt, indicating prudent financial management. The seasoned board and management team further bolster confidence in its operations. However, earnings growth has decelerated compared to the past five years but remains robust overall. Click here and access our complete financial health analysis report to understand the dynamics of Emerald Resources. Explore Emerald Resources' analyst forecasts in our growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Lindsay Australia Limited offers integrated transport, logistics, and rural supply services to the food processing, food services, fresh produce, and horticulture sectors in Australia, with a market cap of A$225.19 million. Operations: The company's revenue is primarily derived from its Transport segment at A$573.35 million, followed by Rural at A$160.92 million and Hunters at A$100.09 million, with an additional contribution from Corporate activities amounting to A$5.15 million. Market Cap: A$225.19M Lindsay Australia presents a mixed picture for investors. While its earnings have grown significantly over the past five years, recent performance shows negative earnings growth and a decline in profit margins. The company's short-term assets exceed its short-term liabilities, but they fall short of covering long-term liabilities. Despite trading below estimated fair value and having well-covered debt by operating cash flow, the stock's return on equity is low and dividend track record unstable. Recent strategic moves include potential acquisition talks with SRT Logistics and a board addition of an experienced non-executive director, which might influence future growth prospects. Jump into the full analysis health report here for a deeper understanding of Lindsay Australia. Gain insights into Lindsay Australia's future direction by reviewing our growth report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Qualitas (ASX:QAL) is a real estate investment firm specializing in direct investments across various real estate classes and geographies, distressed debt acquisitions and restructuring, third-party capital raisings, and consulting services, with a market cap of A$833.42 million. Operations: Qualitas generates revenue through its Direct Lending segment, which accounts for A$23.03 million, and its Funds Management segment, contributing A$21.46 million. Market Cap: A$833.42M Qualitas demonstrates a robust financial position with significant earnings growth of 21.6% annually over the past five years, supported by strong net profit margins that have improved to 27.6%. The company's short-term assets comfortably cover both short- and long-term liabilities, and it holds more cash than total debt. However, its dividend yield of 2.82% is not well covered by free cash flows, and operating cash flow remains negative. Recent developments include the appointment of Bruce MacDiarmid as an independent non-executive director, potentially enhancing governance given his extensive experience in investment banking and capital markets. Take a closer look at Qualitas' potential here in our financial health report. Understand Qualitas' earnings outlook by examining our growth report. Unlock more gems! Our ASX Penny Stocks screener has unearthed 997 more companies for you to here to unveil our expertly curated list of 1,000 ASX Penny Stocks. Curious About Other Options? Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:EMR ASX:LAU and ASX:QAL. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
02-06-2025
- Business
- Yahoo
ASX Penny Stocks To Watch In June 2025
The ASX200 is set to open slightly lower today, influenced by mixed performances in the US markets and ongoing global trade tensions. Despite these broader market challenges, penny stocks—often representing smaller or newer companies—continue to offer intriguing opportunities for growth. While the term 'penny stock' may seem outdated, these investments can still reveal hidden value when backed by strong financial health and solid fundamentals. Name Share Price Market Cap Financial Health Rating Lindsay Australia (ASX:LAU) A$0.71 A$225.19M ★★★★☆☆ CTI Logistics (ASX:CLX) A$1.85 A$149.01M ★★★★☆☆ Accent Group (ASX:AX1) A$1.90 A$1.14B ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$1.565 A$73.83M ★★★★★★ IVE Group (ASX:IGL) A$2.55 A$393.16M ★★★★★☆ GTN (ASX:GTN) A$0.61 A$116.42M ★★★★★★ Bisalloy Steel Group (ASX:BIS) A$3.50 A$166.08M ★★★★★★ Regal Partners (ASX:RPL) A$2.33 A$783.26M ★★★★★★ Tasmea (ASX:TEA) A$2.99 A$699.78M ★★★★★☆ SHAPE Australia (ASX:SHA) A$3.29 A$272.21M ★★★★★★ Click here to see the full list of 1,000 stocks from our ASX Penny Stocks screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Emerald Resources NL is involved in the exploration and development of mineral reserves in Cambodia and Australia, with a market cap of A$3.12 billion. Operations: The company generates revenue primarily from its mine operations, amounting to A$427.32 million. Market Cap: A$3.12B Emerald Resources demonstrates strong financial health with its interest payments well covered by EBIT and operating cash flow covering debt over tenfold. Its net profit margin has improved, reflecting a stable growth trajectory, while earnings have consistently outpaced the industry average. The company trades significantly below estimated fair value and has not diluted shareholders recently. Despite a low return on equity, Emerald's cash reserves exceed total debt, indicating prudent financial management. The seasoned board and management team further bolster confidence in its operations. However, earnings growth has decelerated compared to the past five years but remains robust overall. Click here and access our complete financial health analysis report to understand the dynamics of Emerald Resources. Explore Emerald Resources' analyst forecasts in our growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Lindsay Australia Limited offers integrated transport, logistics, and rural supply services to the food processing, food services, fresh produce, and horticulture sectors in Australia, with a market cap of A$225.19 million. Operations: The company's revenue is primarily derived from its Transport segment at A$573.35 million, followed by Rural at A$160.92 million and Hunters at A$100.09 million, with an additional contribution from Corporate activities amounting to A$5.15 million. Market Cap: A$225.19M Lindsay Australia presents a mixed picture for investors. While its earnings have grown significantly over the past five years, recent performance shows negative earnings growth and a decline in profit margins. The company's short-term assets exceed its short-term liabilities, but they fall short of covering long-term liabilities. Despite trading below estimated fair value and having well-covered debt by operating cash flow, the stock's return on equity is low and dividend track record unstable. Recent strategic moves include potential acquisition talks with SRT Logistics and a board addition of an experienced non-executive director, which might influence future growth prospects. Jump into the full analysis health report here for a deeper understanding of Lindsay Australia. Gain insights into Lindsay Australia's future direction by reviewing our growth report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Qualitas (ASX:QAL) is a real estate investment firm specializing in direct investments across various real estate classes and geographies, distressed debt acquisitions and restructuring, third-party capital raisings, and consulting services, with a market cap of A$833.42 million. Operations: Qualitas generates revenue through its Direct Lending segment, which accounts for A$23.03 million, and its Funds Management segment, contributing A$21.46 million. Market Cap: A$833.42M Qualitas demonstrates a robust financial position with significant earnings growth of 21.6% annually over the past five years, supported by strong net profit margins that have improved to 27.6%. The company's short-term assets comfortably cover both short- and long-term liabilities, and it holds more cash than total debt. However, its dividend yield of 2.82% is not well covered by free cash flows, and operating cash flow remains negative. Recent developments include the appointment of Bruce MacDiarmid as an independent non-executive director, potentially enhancing governance given his extensive experience in investment banking and capital markets. Take a closer look at Qualitas' potential here in our financial health report. Understand Qualitas' earnings outlook by examining our growth report. Unlock more gems! Our ASX Penny Stocks screener has unearthed 997 more companies for you to here to unveil our expertly curated list of 1,000 ASX Penny Stocks. Curious About Other Options? Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:EMR ASX:LAU and ASX:QAL. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25-05-2025
- Business
- Yahoo
3 ASX Penny Stocks With Market Caps Below A$300M
As the Australian market prepares for a modest 0.17% gain, investors are keeping a close eye on global events and their potential impact on local indices. For those willing to explore beyond well-known stocks, penny stocks present intriguing opportunities despite being considered an outdated term. These smaller or newer companies often combine affordability with growth potential, and we'll explore three such stocks that stand out for their financial strength and hidden value. Name Share Price Market Cap Financial Health Rating Lindsay Australia (ASX:LAU) A$0.685 A$217.26M ★★★★☆☆ CTI Logistics (ASX:CLX) A$1.78 A$143.37M ★★★★☆☆ Accent Group (ASX:AX1) A$1.905 A$1.15B ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$1.505 A$71M ★★★★★★ IVE Group (ASX:IGL) A$2.57 A$396.25M ★★★★★☆ GTN (ASX:GTN) A$0.60 A$114.64M ★★★★★★ Bisalloy Steel Group (ASX:BIS) A$3.64 A$172.72M ★★★★★★ Regal Partners (ASX:RPL) A$2.16 A$726.11M ★★★★★★ Navigator Global Investments (ASX:NGI) A$1.685 A$825.78M ★★★★★☆ Tasmea (ASX:TEA) A$2.93 A$685.73M ★★★★★☆ Click here to see the full list of 997 stocks from our ASX Penny Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Bisalloy Steel Group Limited manufactures and sells quenched and tempered, high-tensile, and abrasion-resistant steel plates in Australia, Indonesia, Thailand, and internationally with a market cap of A$172.72 million. Operations: The company generates revenue primarily from its operations in Australia, amounting to A$103.30 million. Market Cap: A$172.72M Bisalloy Steel Group demonstrates a solid financial position with earnings growth of 14% over the past year, surpassing the industry average. The company's high Return on Equity of 21.7% and strong cash flow coverage of debt underscore its financial health. Despite unstable dividends, Bisalloy's net profit margins have improved to 11%, and its short-term assets comfortably cover liabilities. Recent inclusion in the S&P/ASX All Ordinaries Index reflects market confidence, while stable weekly volatility suggests consistent performance. However, sales have slightly decreased year-on-year, indicating potential challenges in revenue generation amidst otherwise robust fundamentals. Jump into the full analysis health report here for a deeper understanding of Bisalloy Steel Group. Learn about Bisalloy Steel Group's future growth trajectory here. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Fleetwood Limited operates in the design, manufacture, sale, and installation of modular accommodation and buildings across Australia and New Zealand, with a market cap of A$265.65 million. Operations: The company generates revenue through its RV Solutions segment with A$71.51 million, Building Solutions contributing A$340.12 million, and Community Solutions adding A$50.02 million. Market Cap: A$265.65M Fleetwood Limited, with a market cap of A$265.65 million, operates debt-free and has seen its earnings grow by 9.6% annually over the past five years. Despite recent negative earnings growth of -31.8%, the company reported half-year sales of A$271.94 million, up from A$228.92 million the previous year, alongside a net income increase to A$4.66 million from A$3.86 million year-on-year. Fleetwood's dividend yield of 8.07% is not well-covered by earnings, yet it recently declared an increased fully franked dividend per share for six months ended December 2024 amidst stable weekly volatility and significant share buybacks completed in late 2024. Navigate through the intricacies of Fleetwood with our comprehensive balance sheet health report here. Examine Fleetwood's earnings growth report to understand how analysts expect it to perform. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Southern Palladium Limited, with a market cap of A$31.83 million, is involved in the exploration and development of platinum group metals through its subsidiaries. Operations: Southern Palladium Limited does not report any revenue segments. Market Cap: A$31.83M Southern Palladium Limited, with a market cap of A$31.83 million, remains pre-revenue but shows potential through strategic developments in its Bengwenyama platinum group metals project. The recent Environmental Authorisation paves the way for mining rights, reflecting strong permitting work and commitment to responsible development. The company is refining its Pre-Feasibility Study with a focus on reducing initial capital requirements by implementing a two-stage development strategy. Despite ongoing losses and high share price volatility, Southern Palladium's debt-free status and sufficient cash runway provide financial stability as it progresses towards project execution. Dive into the specifics of Southern Palladium here with our thorough balance sheet health report. Assess Southern Palladium's previous results with our detailed historical performance reports. Unlock more gems! Our ASX Penny Stocks screener has unearthed 994 more companies for you to here to unveil our expertly curated list of 997 ASX Penny Stocks. Searching for a Fresh Perspective? AI is about to change healthcare. These 22 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:BIS ASX:FWD and ASX:SPD. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13-05-2025
- Business
- Yahoo
3 ASX Penny Stocks With Market Caps Larger Than A$500M
The Australian market recently experienced a boost following a policy reversal by Trump, which provided temporary relief on tariffs for China. In such fluctuating conditions, investors often seek opportunities in smaller or newer companies that can offer both affordability and potential growth. Despite the somewhat outdated term, penny stocks remain relevant as an investment area, with some demonstrating financial strength and stability that could appeal to those looking for hidden gems in the market. Name Share Price Market Cap Financial Health Rating CTI Logistics (ASX:CLX) A$1.78 A$143.37M ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$1.46 A$68.87M ★★★★★★ IVE Group (ASX:IGL) A$2.67 A$411.67M ★★★★★☆ GTN (ASX:GTN) A$0.62 A$118.5M ★★★★★★ West African Resources (ASX:WAF) A$2.27 A$2.59B ★★★★★★ GR Engineering Services (ASX:GNG) A$2.79 A$466.92M ★★★★★★ Bisalloy Steel Group (ASX:BIS) A$3.35 A$158.96M ★★★★★★ Regal Partners (ASX:RPL) A$2.43 A$816.88M ★★★★★★ Navigator Global Investments (ASX:NGI) A$1.67 A$818.43M ★★★★★☆ NRW Holdings (ASX:NWH) A$2.90 A$1.33B ★★★★★☆ Click here to see the full list of 994 stocks from our ASX Penny Stocks screener. We'll examine a selection from our screener results. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Clarity Pharmaceuticals Ltd is a clinical stage radiopharmaceutical company focused on the research and development of radiopharmaceutical products in Australia and the United States, with a market cap of A$822.66 million. Operations: Clarity Pharmaceuticals generates revenue through its radiopharmaceutical development segment, amounting to A$10.78 million. Market Cap: A$822.66M Clarity Pharmaceuticals, with a market cap of A$822.66 million, is navigating the penny stock landscape with its focus on radiopharmaceuticals. Despite being unprofitable and experiencing increased losses over the past five years, Clarity's strategic moves are noteworthy. The company has secured a commercial-scale supply agreement for copper-64 with Nusano, enhancing its capacity for large-scale production in the US market. Additionally, Clarity's SECuRE trial is advancing to Phase II following promising results in prostate cancer treatment. With sufficient cash runway and no debt burden, Clarity positions itself strategically within this niche sector despite high volatility challenges. Navigate through the intricacies of Clarity Pharmaceuticals with our comprehensive balance sheet health report here. Learn about Clarity Pharmaceuticals' future growth trajectory here. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Civmec Limited is an investment holding company that offers construction and engineering services across the energy, resources, infrastructure, marine, and defense sectors in Australia, with a market cap of A$503.44 million. Operations: The company generates revenue from several segments, including A$38.78 million from Energy, A$864.53 million from Resources, and A$140.68 million from Infrastructure, Marine & Defence. Market Cap: A$503.44M Civmec Limited, with a market cap of A$503.44 million, is actively expanding its footprint in the construction and engineering sectors through significant contract awards and extensions valued at approximately A$285 million. The company's recent projects, including the Port Waratah shiploader project and Eneabba rare earths refinery works, underscore its robust order book and client confidence. Despite facing challenges such as lower net profit margins compared to last year and negative earnings growth over the past year, Civmec maintains financial stability with satisfactory debt levels and strong asset coverage for liabilities. Its dividend yield remains attractive but is not well covered by free cash flows. Unlock comprehensive insights into our analysis of Civmec stock in this financial health report. Examine Civmec's earnings growth report to understand how analysts expect it to perform. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Stanmore Resources Limited is involved in the exploration, development, production, and sale of metallurgical coal in Australia, with a market cap of A$1.78 billion. Operations: The company generates revenue from its Metals & Mining segment, specifically through coal, amounting to $2.40 billion. Market Cap: A$1.78B Stanmore Resources, with a market cap of A$1.78 billion, has seen its revenue decline to US$2.50 billion for 2024 from the previous year. Despite this, it maintains stable debt levels with a net debt to equity ratio of 1% and adequate interest coverage at 3.5 times EBIT. Short-term assets exceed liabilities, though long-term liabilities remain uncovered by short-term assets. The company's profit margins have decreased significantly from last year, and earnings are projected to decline further over the next three years. Its dividend yield is high but not supported by free cash flows, indicating potential sustainability concerns. Jump into the full analysis health report here for a deeper understanding of Stanmore Resources. Evaluate Stanmore Resources' prospects by accessing our earnings growth report. Get an in-depth perspective on all 994 ASX Penny Stocks by using our screener here. Contemplating Other Strategies? AI is about to change healthcare. These 23 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:CU6 ASX:CVL and ASX:SMR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13-05-2025
- Business
- Yahoo
ASX Penny Stock Highlights For May 2025
The ASX200 is set to open 1.18% higher, reflecting optimism following a temporary tariff cut agreement between China and the United States at a Geneva summit. In light of these market conditions, identifying stocks with strong financials becomes crucial, especially when considering the potential of smaller or newer companies. Penny stocks, although an older term, continue to offer intriguing opportunities for investors seeking affordable entry points with growth potential. Name Share Price Market Cap Financial Health Rating CTI Logistics (ASX:CLX) A$1.75 A$140.95M ★★★★☆☆ Accent Group (ASX:AX1) A$1.925 A$1.09B ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$1.45 A$68.4M ★★★★★★ IVE Group (ASX:IGL) A$2.70 A$416.29M ★★★★★☆ GTN (ASX:GTN) A$0.665 A$127.1M ★★★★★★ West African Resources (ASX:WAF) A$2.42 A$2.76B ★★★★★★ GR Engineering Services (ASX:GNG) A$2.80 A$468.59M ★★★★★★ Bisalloy Steel Group (ASX:BIS) A$3.35 A$158.96M ★★★★★★ Regal Partners (ASX:RPL) A$2.30 A$773.18M ★★★★★★ NRW Holdings (ASX:NWH) A$2.83 A$1.29B ★★★★★☆ Click here to see the full list of 993 stocks from our ASX Penny Stocks screener. Let's explore several standout options from the results in the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Aussie Broadband Limited offers telecommunications and technology services in Australia, with a market cap of A$1.20 billion. Operations: The company's revenue is derived from its Residential segment (A$628.51 million), Wholesale segment (A$143.55 million), Business segment (A$102.99 million), and Enterprise and Government segment (A$93.51 million). Market Cap: A$1.2B Aussie Broadband, with a market cap of A$1.20 billion, is experiencing growth in its earnings and revenue, supported by strong cash flow that covers its debt well. The company has shown improved financial health over the past five years, transitioning from negative to positive shareholder equity. Recent strategic moves include seeking acquisitions to enhance business scale and capability while maintaining a satisfactory net debt to equity ratio of 7.2%. Despite low return on equity at 5%, the board's experience and recent executive changes aim to bolster governance as they pursue further M&A opportunities for growth. Navigate through the intricacies of Aussie Broadband with our comprehensive balance sheet health report here. Learn about Aussie Broadband's future growth trajectory here. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Deep Yellow Limited, with a market cap of A$1.31 billion, is a uranium exploration company operating in Namibia and Australia through its subsidiaries. Operations: Deep Yellow Limited does not report any revenue segments. Market Cap: A$1.31B Deep Yellow Limited, with a market cap of A$1.31 billion, operates as a pre-revenue uranium exploration company. Despite reporting A$6.29 million in revenue for the half-year ended December 2024, it remains unprofitable with net losses narrowing to A$2.47 million from A$6.19 million a year prior. The company benefits from being debt-free and having short-term assets of A$246.1 million that cover both its short- and long-term liabilities comfortably. While earnings are projected to decline significantly over the next three years, Deep Yellow maintains a stable cash runway exceeding three years based on current free cash flow trends. Click here and access our complete financial health analysis report to understand the dynamics of Deep Yellow. Understand Deep Yellow's earnings outlook by examining our growth report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: IGO Limited is an exploration and mining company in Australia that focuses on discovering, developing, and operating assets for metals essential to clean energy, with a market cap of A$3.30 billion. Operations: The company's revenue is primarily generated from its Nova Operation, which contributes A$460.8 million, and the Forrestania Operation, adding A$153 million. Market Cap: A$3.3B IGO Limited, with a market cap of A$3.30 billion, operates in the metals and mining sector focusing on clean energy assets. Despite generating significant revenue from its Nova and Forrestania operations, recent financial results show a net loss of A$782.1 million for the half-year ended December 31, 2024. The company is debt-free, with short-term assets of A$437.5 million exceeding both short- and long-term liabilities comfortably. Management changes are underway as key executives plan to depart by year-end 2025. Although IGO's earnings are forecasted to grow substantially per analyst estimates, current unprofitability remains a challenge for investors considering penny stocks in this sector. Jump into the full analysis health report here for a deeper understanding of IGO. Gain insights into IGO's outlook and expected performance with our report on the company's earnings estimates. Navigate through the entire inventory of 993 ASX Penny Stocks here. Ready For A Different Approach? Outshine the giants: these 28 early-stage AI stocks could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:ABB ASX:DYL and ASX:IGO. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
